Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Previous findings showed that in mice, complete knockout of activity-dependent neuroprotective protein (ADNP) abolishes brain formation, while haploinsufficiency (Adnp+/-) causes cognitive impairments. We hypothesized that mutations in ADNP lead to a developmental/autistic syndrome in children. Indeed, recent phenotypic characterization of children harboring ADNP mutations (ADNP syndrome children) revealed global developmental delays and intellectual disabilities, including speech and motor dysfunctions. Mechanistically, ADNP includes a SIP motif embedded in the ADNP-derived snippet drug candidate NAP (NAPVSIPQ, also known as CP201), which binds to microtubule end-binding protein 3, essential for dendritic spine formation. Here, we established a unique neuronal membrane-tagged, GFP-expressing Adnp+/- mouse line allowing in vivo synaptic pathology quantification. We discovered that Adnp deficiency reduced dendritic spine density and altered synaptic gene expression, both of which were partly ameliorated by NAP treatment. Adnp+/-mice further exhibited global developmental delays, vocalization impediments, gait and motor dysfunctions, and social and object memory impairments, all of which were partially reversed by daily NAP administration (systemic/nasal). In conclusion, we have connected ADNP-related synaptic pathology to developmental and behavioral outcomes, establishing NAP in vivo target engagement and identifying potential biomarkers. Together, these studies pave a path toward the clinical development of NAP (CP201) for the treatment of ADNP syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw937 · Cited by 6,980
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797 · cited 1×
“…dimorphic neurons to regulate sexual behavior, it is now suggested that ADNP and NAP play a part in sexually dichotomous brain plasticity, which is reflected in the above-mentioned changes in den-The jci.org Volume 128 Number 11 November 2018 with autism being a disease of the synapse (69).”
Miniature synaptic events maintain dendritic spines via AMPA receptor activation
McKinney, R. A., Capogna, M., Dürr, R., Gähwiler, B. H., & Thompson, A. S. M. (1999) · Nature Neuroscience · doi:10.1038/4548 · Cited by 523
Self-citationIba1 Is an Actin-Cross-Linking Protein in Macrophages/Microglia
Sasaki, Y., Ohsawa, K., Kanazawa, H., Kohsaka, S., & Imai, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5388 · Cited by 373
A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP
Helsmoortel, C., Vulto-van Silfhout, A. T., Coe, B. P., Vandeweyer, G., Rooms, L., van den Ende, J., Schuurs-Hoeijmakers, J. H. M., Marcelis, C. L., Willemsen, M. H., Vissers, L. E. L. M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2899 · Cited by 354 · cited 9×
“Tyr719* (15) and one was generated from peripheral blood lymphocytes donated by consenting patient/guardians/physicians (18).”
BackgroundResultInfluentialCloning and Characterization of the Human Activity-dependent Neuroprotective Protein
Zamostiano, R., Pinhasov, A., Gelber, E., Steingart, R. A., Seroussi, E., Giladi, E., Bassan, M., Wollman, Y., Eyre, H. J., Mulley, J. C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007416200 · Cited by 251 · cited 2×
“NAP was injected in increasing volumes at 20-and 40-μ l doses on days 1–4 and 5–7, respectively (3, 48).”
Self-citationActivity-dependent neuroprotective protein: a novel gene essential for brain formation
Pinhasov, A., Mandel, S., Torchinsky, A., Giladi, E., Pittel, Z., Goldsweig, A. M., Servoss, S. J., Brenneman, D. E., & Gozes, I. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(03)00162-7 · Cited by 239
Self-citationVulih-Shultzman, I., Pinhasov, A., Mandel, S., Grigoriadis, N., Touloumi, O., Pittel, Z., & Gozes, I. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129551 · Cited by 219
Self-citationDown's dyndrome and Alzheimer's disease: dendritic spine counts in the hippocampus
Ferrer, I., & Gullotta, F. (1990) · Acta Neuropathologica · doi:10.1007/bf00294247 · Cited by 201
Mandel, S., Rechavi, G., & Gozes, I. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.11.039 · Cited by 167
Self-citationGlutamate induces the rapid formation of spine head protrusions in hippocampal slice cultures
Richards, D. A., Mateos, J. M., Hugel, S., de Paola, V., Caroni, P., Gähwiler, B. H., & McKinney, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501881102 · Cited by 161 · cited 1×
“For this purpose, Adnp +/– female mice were crossed with L15 male mice (on a C57BL/6 background) to produce an Adnp mouse model with neuronal GFP expression (72).”
Self-citationRegulation of cerebral cortical neurogenesis by the Pax6 transcription factor
Manuel, M. N., Mi, D., Mason, J. O., & Price, D. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00070 · Cited by 153
Mandel, S., & Gozes, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704756200 · Cited by 150 · cited 3×
“We discovered ADNP 19 years ago (4, 5) and predicted that ADNP deficiency or mutations could lead to an autism-related intellectual disability syndrome in humans on the basis of findings in our mouse models (1, 3, 10, 15, 50, 51).”
Self-citationDocosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology
Chang, P. K.-Y., Khatchadourian, A., McKinney, R. A., & Maysinger, D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0244-5 · Cited by 124
Self-citationMorimoto, B. H., Schmechel, D., Hirman, J., Blackwell, A., Keith, J., Gold, M., & on behalf of the AL-108-211 Study Investigators (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000348347 · Cited by 115
Malishkevich, A., Amram, N., Hacohen-Kleiman, G., Magen, I., Giladi, E., & Gozes, I. (2015) · Translational Psychiatry · doi:10.1038/tp.2014.138 · Cited by 109
Self-citationMandel, S., Spivak-Pohis, I., & Gozes, I. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9013-y · Cited by 91 · cited 2×
“We discovered ADNP 19 years ago (4, 5) and predicted that ADNP deficiency or mutations could lead to an autism-related intellectual disability syndrome in humans on the basis of findings in our mouse models (1, 3, 10, 15, 50, 51).”
Self-citationNeurexin controls plasticity of a mature, sexually dimorphic neuron
Hart, M. P., & Hobert, O. (2018) · Nature · doi:10.1038/nature25192 · Cited by 84 · cited 1×
“We then measured the latency to fall off an inverted cage lid (hanging wire) and dritic spine densities (57).”
Evaluation of Pax6 Mutant Rat as a Model for Autism
Umeda, T., Takashima, N., Nakagawa, R., Maekawa, M., Ikegami, S., Yoshikawa, T., Kobayashi, K., Okanoya, K., Inokuchi, K., & Osumi, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015500 · Cited by 70 · cited 8×
“This effect mimics our current data and is further corroborated by evidence in humans suggesting greater communication deficits in autistic girls than in autistic boys (64).”
InfluentialDresner, E., Malishkevich, A., Arviv, C., Leibman Barak, S., Alon, S., Ofir, R., Gothilf, Y., & Gozes, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387027 · Cited by 47 · cited 2×
“NAP was injected in increasing volumes at 20-and 40-μ l doses on days 1–4 and 5–7, respectively (3, 48).”
Self-citationActivity-Dependent Neuroprotective Protein Modulates Its Own Gene Expression
Aboonq, M. S., Vasiliou, S. A., Haddley, K., Quinn, J. P., & Bubb, V. J. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9562-y · Cited by 23
Cited by
Ivashko-Pachima, Y., Hadar, A., Grigg, I., Korenková, V., Kapitansky, O., Karmon, G., Gershovits, M., Sayas, C. L., Kooy, R. F., Attems, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0563-5 · Cited by 107
“These results pave the path to NAP/ADNP enhancing therapy in the ADNP syndrome (CP201, Coronis Neurosciences) [68] and for NAP and related molecules as preventive treatment in prodromal AD [69].”
Self-citationBennison, S. A., Blazejewski, S. M., Liu, X., Hacohen-Kleiman, G., Sragovich, S., Zoidou, S., Touloumi, O., Grigoriadis, N., Gozes, I., & Toyo-oka, K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01939-3 · Cited by 42
“In the Adnp mice, differential expression of synaptic regulatory proteins attests to a cardinal impact of ADNP/NAP in synaptogenesis [35].”
BackgroundResultInfluentialSelf-citationTeter, O. M., McQuade, A., Hagan, V., Liang, W., Dräger, N. M., Sattler, S. M., Holmes, B. B., Castillo, V. C., Papakis, V., Leng, K., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02997-z · Cited by 38
“Previous work has shown mice with haploinsuf fi cient Adnp have decreased spine density and developmental delays [40 – 42].”
Metadata
- Authors
- Hacohen-Kleiman, G., Sragovich, S., Karmon, G., Gao, A. Y. L., Grigg, I., Pasmanik-Chor, M., Le, A., Korenková, V., McKinney, R. A., & Gozes, I.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-09-24
- Volume
- 128
- Issue
- 11
- Pages
- 4956-4969
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2887450160
- Cited by
- 101
- References
- 23
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.